Recognition of Allergic Conjunctivitis in Patients with Allergic Rhinitis

Overview

Journal World Allergy Organ J

Specialty Allergy & Immunology

Date 2013 May 14

PMID 23663473

Citations 8

Authors

Daniel C Williams

Gabrielle Edney

Bianca Maiden

Peter K Smith

Affiliations

Soon will be listed here.

Abstract

Aims: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis.

Methods: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify "silent" disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms.

Results: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine.

Conclusions: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC.

Citing Articles

IgE Mediated Wheat Allergy Associated with Resistant and Severe Forms of Allergic Conjunctivitis.

Sayed K, Ali A Open Respir Med J. 2023; 16:e187430642208170.

PMID: 37273955 PMC: 10156020. DOI: 10.2174/18743064-v16-e2208170.

The Asthma Risk Is Increased in Children with Severe Allergic Rhinitis.

Kaya Akca U, Maslak I, Uygun D, Bingol A Turk Arch Pediatr. 2022; 57(4):391-397.

PMID: 35822470 PMC: 9476271. DOI: 10.5152/TurkArchPediatr.2022.21269.

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm.

Scadding G, Smith P, Blaiss M, Roberts G, Hellings P, Gevaert P Front Allergy. 2022; 2:706589.

PMID: 35387065 PMC: 8974858. DOI: 10.3389/falgy.2021.706589.

Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis.

Salapatek A, Werkhauser N, Ismail B, Mosges R, Raskopf E, Bilstein A Clin Transl Allergy. 2021; 11(1):e12006.

PMID: 33900046 PMC: 8099269. DOI: 10.1002/clt2.12006.

One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis.

Sayed K, Kamel A, Ali A Graefes Arch Clin Exp Ophthalmol. 2019; 257(9):1989-1996.

PMID: 31209565 DOI: 10.1007/s00417-019-04389-w.

References

Blaiss M . Allergic rhinoconjunctivitis: burden of disease. Allergy Asthma Proc. 2007; 28(4):393-7. DOI: 10.2500/aap.2007.28.3013. View

Rosario N, Bielory L . Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2011; 11(5):471-6. DOI: 10.1097/ACI.0b013e32834a9676. View

Pitt A, Smith A, Lindsell L, Voon L, Rose P, Bron A . Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol. 2004; 11(1):17-33. DOI: 10.1076/opep.11.1.17.26437. View

Nathan R, Meltzer E, Derebery J, Campbell U, Stang P, Corrao M . The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc. 2009; 29(6):600-8. DOI: 10.2500/aap.2008.29.3179. View

Wuthrich B, Brignoli R, Canevascini M, Gerber M . Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr. 1998; 128(5):139-43. View

Braun-Fahrlander C, Wuthrich B, Gassner M, Grize L, Sennhauser F, Varonier H . Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. SCARPOL-team. Swiss Study on Childhood Allergy and Respiratory Symptom with respect to Air Pollution.... Pediatr Allergy Immunol. 1997; 8(2):75-82. DOI: 10.1111/j.1399-3038.1997.tb00147.x. View

Meltzer E . The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997; 99(6 Pt 2):S805-28. View

Austin J, Kaur B, Anderson H, Burr M, Harkins L, Strachan D . Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood). Arch Dis Child. 1999; 81(3):225-30. PMC: 1718047. DOI: 10.1136/adc.81.3.225. View

Ono S, Abelson M . Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005; 115(1):118-22. DOI: 10.1016/j.jaci.2004.10.042. View

10.

DeWester J, Philpot E, Westlund R, Cook C, Rickard K . The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003; 24(5):331-7. View

11.

Bauchau V, Durham S . Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004; 24(5):758-64. DOI: 10.1183/09031936.04.00013904. View

12.

Yanni J, Weimer L, Sharif N, Xu S, Gamache D, Spellman J . Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol. 1999; 117(5):643-7. DOI: 10.1001/archopht.117.5.643. View

13.

Bielory L . Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep. 2010; 10(2):122-34. DOI: 10.1007/s11882-010-0087-1. View

14.

Sharif N, Xu S, Yanni J . Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. J Ocul Pharmacol Ther. 1996; 12(4):401-7. DOI: 10.1089/jop.1996.12.401. View

15.

Neffen H, Mello Jr J, Sole D, Naspitz C, Dodero A, Garza H . Nasal allergies in the Latin American population: results from the Allergies in Latin America survey. Allergy Asthma Proc. 2010; 31 Suppl 1:S9-27. DOI: 10.2500/aap.2010.31.3347. View

16.

Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson H . Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1998; 8(4):161-76. DOI: 10.1111/j.1399-3038.1997.tb00156.x. View

17.

Yanni J, Stephens D, Miller S, Weimer L, Graff G, Parnell D . The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther. 1996; 12(4):389-400. DOI: 10.1089/jop.1996.12.389. View

18.

Bousquet J, Van Cauwenberge P, Khaltaev N . Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108(5 Suppl):S147-334. DOI: 10.1067/mai.2001.118891. View